Cormorant Asset Management, LP - SYNAGEVA BIOPHARMA CORP ownership

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of SYNAGEVA BIOPHARMA CORP
ValueSharesWeighting
Q1 2015$4,145,000
-55.3%
42,500
-57.5%
0.64%
-55.2%
Q4 2014$9,279,000
+34.9%
100,0000.0%1.43%
+1.1%
Q3 2014$6,878,000100,0001.42%
Other shareholders
SYNAGEVA BIOPHARMA CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Baker Brothers Advisors 10,660,432$1,117,213,00013.68%
BB BIOTECH AG 898,476$94,160,0004.47%
SECTORAL ASSET MANAGEMENT INC 516,445$54,123,0002.29%
Ghost Tree Capital, LLC 30,000$3,144,0002.22%
COLUMBIA WANGER ASSET MANAGEMENT LLC 3,521,000$369,001,0001.48%
Pier Capital, LLC 83,493$8,750,0001.24%
ArrowMark Colorado Holdings LLC 197,613$20,710,0000.59%
PALISADE CAPITAL MANAGEMENT, LP 120,779$12,658,0000.31%
FORTALEZA ASSET MANAGEMENT INC/ 5,440$570,0000.26%
Tradeworx Inc. 2,936$308,0000.25%
View complete list of SYNAGEVA BIOPHARMA CORP shareholders